JAM-A staining was negative in 7.1% of primary tumours and in 14.3% of paired metastases, while a patchy cytoplasmic expression pattern was observed in 48.2% of primary tumours and in 44.6% of paired metastases (Fig. 1B). This evidence concerns the gene F11R and neoplasm.